Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2013 - New Market Study Published
Global Markets Direct's, 'Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Transitional Cell Carcinoma (Urothelial Cell Carcinoma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Transitional Cell Carcinoma (Urothelial Cell Carcinoma). Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, Half Year is built using...
View full press release